Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rush

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
JCI Insight|July 8, 2022
Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractantsThomas Hoyler, Bettina Bannert, Cédric André, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
The Journal of Clinical Investigation|May 25, 2023
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
Science Advances|March 25, 2026
A conserved glycan motif induces broadly reactive functional antibodies against the zoonotic pathogen <i>Streptococcus suis</i>Yao Shi, Göran Widmalm, Charlotte Sorieul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of PathologyDavid Cohen, Timothy Craig Allen, Serdar Balci, et al.
Cell Reports. Medicine|May 17, 2023
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapyStuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2015
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammationFrédéric Bornancin, Florian Renner, Ratiba Touil, et al.
The Lancet. Rheumatology|January 24, 2024
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept studyBenjamin A Fisher, Antonia Szanto, Wan-Fai Ng, et al.
JCI Insight|February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumorsStergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
JCI Insight|July 8, 2022
Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractantsThomas Hoyler, Bettina Bannert, Cédric André, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
The Journal of Clinical Investigation|May 25, 2023
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonalityTiffany Shi, Ashley R Burg, J Timothy Caldwell, et al.
Science Advances|March 25, 2026
A conserved glycan motif induces broadly reactive functional antibodies against the zoonotic pathogen <i>Streptococcus suis</i>Yao Shi, Göran Widmalm, Charlotte Sorieul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of PathologyDavid Cohen, Timothy Craig Allen, Serdar Balci, et al.
Cell Reports. Medicine|May 17, 2023
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapyStuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, et al.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2015
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammationFrédéric Bornancin, Florian Renner, Ratiba Touil, et al.
The Lancet. Rheumatology|January 24, 2024
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept studyBenjamin A Fisher, Antonia Szanto, Wan-Fai Ng, et al.
JCI Insight|February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumorsStergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Pageof 30